Abstract
Key content Treatment options for stress urinary incontinence (SUI) include physical therapies and a range of surgical options. Urethral bulking agents may be used as a surgical treatment for SUI. There are different types of bulking agents, with varying complications and outcomes. We discuss the impact of the current UK pause for vigilance and restriction on the use of mesh in the treatment of SUI. Learning objectives To gain an overview of the history of bulking agents. To understand the properties of commonly used bulking agents. To understand the clinical indications and evidence on efficacy and complications of urethral bulking agents. Ethical considerations Should urethral bulking agents be used as a first‐line treatment for SUI? Should the introduction of new urethral bulking agents be undertaken within a clinical research trial in light of lessons learned from the introduction of vaginal mesh implants? Women with SUI should be counselled on both surgical and nonsurgical options. There is an absence of long‐term safety and outcome data for newer bulking agents.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
